Lansdall CJ, McDougall F, Butler LM, Delmar P, Pross N, Qin S, McLeod L, Zhou X, Kerchner GA, Doody RS. Establishing clinically meaningful change on outcome assessments frequently used in trials of mild cognitive impairment due to Alzheimer's disease. J Prev Alzheimers Dis. 2023;10(1):9-18. doi: 10.14283/jpad.2022.102
Romano (DeMuro) C, Novak G, Choi J, Qin S, Henley D, Donohue M, Romano G, Raman R, Amariglio R, Aisen P, Sperling R. Assessing clinically meaningful functional outcomes in preclinical alzheimer's disease. Poster presented at the 15th Conference Clinical Trials Alzheimer's Disease 2022; November 29, 2022. San Francisco, CA. [abstract] J Prev Alzheimers Dis. 2022 Dec 3; 9(Supplement 1):S186-7.
Zafeiridi E, McMichael A, Mirakhur A, McHenry M, Holmes C, McGuinness B. Are tumour necrosis factor inhibitor drugs associated with a lower risk of dementia? Int J Geriatr Psych. 2020 Jul;35(7):802-3. doi: 10.1002/gps.5297
Hill NL, Mogle J, Bell TR, Bhargava S, Wion RK, Bhang I. Predicting current and future anxiety symptoms in cognitively intact older adults with memory complaints. Int J Geriatr Psych. 2019 Dec;34(12):1874-82. doi: 10.1002/gps.5204
Aguado J, Campbell A, Ascaso C, Navarro P, Garcia-Esteve L, Luciano JV. Examining the factor structure and discriminant validity of the 12-Item General Health Questionnaire (GHQ-12) among Spanish postpartum women. Assessment. 2012 Dec 19;19(4):517-25.